Showing results (81-90 of 142) with videos related to
Sort By:
Pageof 15
Journal of the National Cancer Institute|May 10, 1989
Phase I study of an anti-breast cancer immunotoxin by continuous infusion: report of a targeted toxic effect not predicted by animal studiesB J Gould, M J Borowitz, E S Groves, et al.Annals of Plastic Surgery|September 1, 1995
Lasting success in teenage reduction mammaplastyJ D McMahan, J A Wolfe, B A Cromer, et al.Blood|July 1, 1988
Asynchronous antigen expression in B lineage acute lymphoblastic leukemiaC A Hurwitz, M R Loken, M L Graham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Consolidation therapy with antimetabolite-based therapy in standard-risk acute lymphocytic leukemia of childhood: a Pediatric Oncology Group StudyM B Harris, J J Shuster, D J Pullen, et al.The American Journal of Surgical Pathology|October 23, 1997
Blastic natural killer cell leukemia/lymphoma: a clinicopathologic studyJ A DiGiuseppe, D C Louie, J E Williams, et al.Blood|August 15, 1993
Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group studyM J Borowitz, S P Hunger, A J Carroll, et al.American Journal of Clinical Pathology|January 1, 1989
The correlation of mononuclear cell phenotype in endomyocardial biopsies with clinical history and cardiac dysfunctionP C Kolbeck, C Steenbergen, J A Wolfe, et al.Transplantation|February 1, 1987
Infiltrating cell phenotypes and patterns associated with hepatic allograft rejection or acceptanceS J Knechtle, J A Wolfe, J Burchette, et al.Cancer Genetics and Cytogenetics|February 1, 1992
t(2;14)(p13;q32): a recurring abnormality in lymphocytic leukemia. A Pediatric Oncology Group studyM S Watson, V J Land, A J Carroll, et al.Leukemia|September 20, 2000
Treatment of children with early pre-B and pre-B acute lymphocytic leukemia with antimetabolite-based intensification regimens: a Pediatric Oncology Group StudyM B Harris, J J Shuster, J Pullen, et al.Pageof 15